RAC 2.92% $1.94 race oncology ltd

Ann: June 2018 Quarterly Report, page-9

  1. 709 Posts.
    lightbulb Created with Sketch. 649

    Just an "if you're interested" #2: New video interview of Peter Molloy (relesed 22 hours ago via Finance News Network), Race Oncology CEO, with FNN's where he discusses the upcoming IND Application with the US FDA:


    https://www.finnewsnetwork.com.au/archives/finance_news_network200939.html


    Quite remarkable valuation here (10m market MC and $7m EV at .14. Due a major rerate especially considering BIT 25x more expensive earlier this week and we are much much more advanced than ANP but a quarter of their current market cap). 


    Cheers,


    5x8's


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.